Proposed Information Collection Activity; Social Services Block Grant (SSBG) Post-Expenditure Report, Pre-Expenditure Report, and Intended Use Plan, 79185-79186 [2020-27015]
Download as PDF
79185
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials are part of
the public record and are subject to
public disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
CDC does not accept comment by email.
Written Public Comment: Written
comments must be received on or before
December 14, 2020. Oral Public
Comment: This meeting will include
time for members of the public to make
an oral comment. Oral public comment
will occur before any scheduled votes
including all votes relevant to the
ACIP’s Affordable Care Act and
Vaccines for Children Program roles.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the procedures below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the December 13,
2020 ACIP meeting must submit a
request at https://www.cdc.gov/vaccines/
acip/meetings/ no later than 11:59 p.m.,
EST, December 11, 2020 according to
the instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by 12:00 p.m., EST, December 12, 2020.
To accommodate the significant interest
in participation in the oral public
comment session of ACIP meetings,
each speaker will be limited to 3
minutes, and each speaker may only
speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–27133 Filed 12–7–20; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[OMB No. 0970–0234]
Proposed Information Collection
Activity; Social Services Block Grant
(SSBG) Post-Expenditure Report, PreExpenditure Report, and Intended Use
Plan
Office of Community Services,
Administration for Children and
Families, HHS.
ACTION: Request for Public Comment.
AGENCY:
The Administration for
Children and Families (ACF) is
requesting a revision to the Social
Services Block Grant (SSBG) PostExpenditure Report, Pre-Expenditure
Report, and Intended Use Plan (OMB
#0970–0234), previously titled, ‘‘Social
Services Block Grant (SSBG) PostExpenditure Report’’). ACF is proposing
to expand the information collection to
include the collection of states’
Intended Use Plans and retitle the
information collection to clarify the role
of the Pre-Expenditure Report.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
SUMMARY:
Administration for Children and
Families, Office of Planning, Research,
and Evaluation (OPRE), 330 C Street
SW, Washington, DC 20201, Attn: ACF
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: On an annual basis,
states and territories are required to
submit the following reports: (1) An
Intended Use Plan that provides data
and narrative descriptions related to the
state’s SSBG program. The Intended Use
Plan includes details about the delivery
of SSBG services and the state agency
administering the SSBG Program. ACF
is proposing to expand the currently
approved information collection to
include collection of states’ Intended
Use Plans. Grantees are required to
submit their Intended Use Plans no less
than 30 days prior to the start of the
budget period covered by the report. (2)
A Pre-Expenditure Report that
demonstrates the state’s anticipated
allocation of SSBG funding among the
29 pre-defined SSBG service categories.
Historically, states have submitted this
report using the Post-Expenditure
Report Form, and the associated burden
is included in the currently approved
information collection. Grantees are
required to submit their PreExpenditure Report no less than 30 days
prior to the start of the budget period
covered by the report. (3) A PostExpenditure Report that details the
state’s actual use of SSBG funding
among each of the 29 service categories.
Grantees are required to submit their
Post-Expenditure Report within 6
months of the end of the period covered
by the report.
Respondents: Agencies that
administer the SSBG at the state or
territory level, including the 50 states;
District of Columbia; Puerto Rico; and
the territories of American Samoa,
Guam, the Virgin Islands, and the
Commonwealth of Northern Mariana
Islands.
Annual Burden Estimates
This request is specific to the
Intended Use Plan. Currently approved
materials and associated burden can be
found at: https://www.reginfo.gov/
public/do/PRAViewICR?ref_nbr=
202011-0970-006.
Instrument
Annual number
of respondents
Annual number
of responses
per respondent
Average burden
hours per
response
Total/annual
burden hours
Intended Use Plan ...................................................................................
56
1
40
2,240
VerDate Sep<11>2014
16:16 Dec 08, 2020
Jkt 253001
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
E:\FR\FM\09DEN1.SGM
09DEN1
79186
Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices
Estimated Total Annual Burden
Hours: 2,240.
Comments: The Department
specifically requests comments on (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 1397 through 1397e.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–27015 Filed 12–8–20; 8:45 am]
BILLING CODE 4184–24–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1076]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Formal Dispute
Resolution: Scientific and Technical
Issues Related to Pharmaceutical
Current Good Manufacturing Practice
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, Agency, or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection pertaining to Formal Dispute
Resolution: Scientific and Technical
Issues Related to Pharmaceutical
Current Good Manufacturing Practice.
DATES: Submit either electronic or
written comments on the collection of
information by February 8, 2021.
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:16 Dec 08, 2020
Jkt 253001
You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before February 8,
2021. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of February 8, 2021.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
ADDRESSES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2014–N–1076 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request; Guidance
for Industry on Formal Dispute
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Resolution: Scientific and Technical
Issues Related to Pharmaceutical
Current Good Manufacturing Practice.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3521), Federal
E:\FR\FM\09DEN1.SGM
09DEN1
Agencies
[Federal Register Volume 85, Number 237 (Wednesday, December 9, 2020)]
[Notices]
[Pages 79185-79186]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27015]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
[OMB No. 0970-0234]
Proposed Information Collection Activity; Social Services Block
Grant (SSBG) Post-Expenditure Report, Pre-Expenditure Report, and
Intended Use Plan
AGENCY: Office of Community Services, Administration for Children and
Families, HHS.
ACTION: Request for Public Comment.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) is
requesting a revision to the Social Services Block Grant (SSBG) Post-
Expenditure Report, Pre-Expenditure Report, and Intended Use Plan (OMB
#0970-0234), previously titled, ``Social Services Block Grant (SSBG)
Post-Expenditure Report''). ACF is proposing to expand the information
collection to include the collection of states' Intended Use Plans and
retitle the information collection to clarify the role of the Pre-
Expenditure Report.
DATES: Comments due within 60 days of publication. In compliance with
the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995, ACF is soliciting public comment on the specific aspects
of the information collection described above.
ADDRESSES: Copies of the proposed collection of information can be
obtained and comments may be forwarded by emailing
[email protected]. Alternatively, copies can also be obtained
by writing to the Administration for Children and Families, Office of
Planning, Research, and Evaluation (OPRE), 330 C Street SW, Washington,
DC 20201, Attn: ACF Reports Clearance Officer. All requests, emailed or
written, should be identified by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: On an annual basis, states and territories are
required to submit the following reports: (1) An Intended Use Plan that
provides data and narrative descriptions related to the state's SSBG
program. The Intended Use Plan includes details about the delivery of
SSBG services and the state agency administering the SSBG Program. ACF
is proposing to expand the currently approved information collection to
include collection of states' Intended Use Plans. Grantees are required
to submit their Intended Use Plans no less than 30 days prior to the
start of the budget period covered by the report. (2) A Pre-Expenditure
Report that demonstrates the state's anticipated allocation of SSBG
funding among the 29 pre-defined SSBG service categories. Historically,
states have submitted this report using the Post-Expenditure Report
Form, and the associated burden is included in the currently approved
information collection. Grantees are required to submit their Pre-
Expenditure Report no less than 30 days prior to the start of the
budget period covered by the report. (3) A Post-Expenditure Report that
details the state's actual use of SSBG funding among each of the 29
service categories. Grantees are required to submit their Post-
Expenditure Report within 6 months of the end of the period covered by
the report.
Respondents: Agencies that administer the SSBG at the state or
territory level, including the 50 states; District of Columbia; Puerto
Rico; and the territories of American Samoa, Guam, the Virgin Islands,
and the Commonwealth of Northern Mariana Islands.
Annual Burden Estimates
This request is specific to the Intended Use Plan. Currently
approved materials and associated burden can be found at: https://www.reginfo.gov/public/do/PRAViewICR?ref_nbr=202011-0970-006.
----------------------------------------------------------------------------------------------------------------
Annual number of Average burden
Instrument Annual number of responses per hours per Total/annual
respondents respondent response burden hours
----------------------------------------------------------------------------------------------------------------
Intended Use Plan....................... 56 1 40 2,240
----------------------------------------------------------------------------------------------------------------
[[Page 79186]]
Estimated Total Annual Burden Hours: 2,240.
Comments: The Department specifically requests comments on (a)
Whether the proposed collection of information is necessary for the
proper performance of the functions of the agency, including whether
the information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 1397 through 1397e.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020-27015 Filed 12-8-20; 8:45 am]
BILLING CODE 4184-24-P